Alector, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Alector, Inc. (ALEC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.73 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 12.73M shares, a 18.79% decline year-over-year.
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 14.18M shares, a 15.83% decline year-over-year.
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 14.23M shares, a 11.81% decline year-over-year.
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 15.68M shares, a 7.18% decline year-over-year.
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 15.39M shares, a 19.98% decline from fiscal 2024.
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 19.24M shares, a 4.83% increase from fiscal 2023.
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 18.35M shares, a 8.41% increase from fiscal 2022.
- Alector, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 16.93M shares, a 29.31% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 12.73M shares 10-Q · filed 2026-08-06 | 12.73M shares 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | 14.18M shares 10-Q · filed 2026-05-07 | |||||
| 2025-12-31 | 15.39M shares 10-K · filed 2026-02-25 | |||||
| 2025-09-30 | 14.23M shares 10-Q · filed 2025-11-06 | 14.23M shares 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | 15.68M shares 10-Q · filed 2026-08-06 | 15.68M shares 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | 16.85M shares 10-Q · filed 2026-05-07 | |||||
| 2024-12-31 | 19.24M shares 10-K · filed 2026-02-25 | |||||
| 2024-09-30 | 16.13M shares 10-Q · filed 2025-11-06 | 16.13M shares 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | 16.89M shares 10-Q · filed 2025-08-07 | 16.89M shares 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | 17.47M shares 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | 18.35M shares 10-K · filed 2025-02-26 | |||||
| 2023-09-30 | 15.31M shares 10-Q · filed 2024-11-06 | 15.31M shares 10-Q · filed 2024-11-06 | ||||
| 2023-06-30 | 15.45M shares 10-Q · filed 2024-08-07 | 15.45M shares 10-Q · filed 2023-08-03 | 15.48M shares 10-Q · filed 2024-08-07 | 15.48M shares 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | 15.95M shares 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | 16.93M shares 10-K · filed 2025-02-26 | |||||
| 2022-09-30 | 14.69M shares 10-Q · filed 2023-11-07 | 14.69M shares 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | 14.08M shares 10-Q · filed 2023-08-03 | 15.20M shares 10-Q · filed 2023-08-03 | ||||
| 2022-03-31 | 13.93M shares 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | 13.09M shares 10-K · filed 2024-02-27 | |||||
| 2021-09-30 | 2.16M shares 10-Q · filed 2022-11-08 | 4.95M shares 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | 13.56M shares 10-Q · filed 2022-08-04 | 13.56M shares 10-Q · filed 2022-08-04 | 10.07M shares 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | 12.82M shares 10-Q · filed 2022-05-05 | |||||
| 2020-12-31 | 12.93M shares 10-K · filed 2023-02-28 | |||||
| 2020-09-30 | 10.47M shares 10-Q · filed 2021-11-04 | 10.47M shares 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | 10.07M shares 10-Q · filed 2020-08-11 | 10.07M shares 10-Q · filed 2020-08-11 | ||||
| 2020-03-31 | 9.90M shares 10-Q · filed 2021-05-05 | |||||
| 2019-12-31 | 9.48M shares 10-K · filed 2022-02-24 | |||||
| 2019-09-30 | 7.16M shares 10-Q · filed 2020-11-10 | 7.16M shares 10-Q · filed 2020-11-10 | ||||
| 2019-06-30 | 7.12M shares 10-Q · filed 2020-08-11 | 7.12M shares 10-Q · filed 2020-08-11 | ||||
| 2019-03-31 | 7.20M shares 10-Q · filed 2020-05-13 | |||||
| 2018-12-31 | 52.36M shares 10-K · filed 2021-02-25 | |||||
| 2018-09-30 | 50.56M shares 10-Q · filed 2019-11-12 | 50.56M shares 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | 43.73M shares 10-Q · filed 2019-08-12 | 43.73M shares 10-Q · filed 2019-08-12 | ||||
| 2018-03-31 | 38.87M shares 10-Q · filed 2019-05-13 | |||||
| 2017-12-31 | 39.17M shares 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |